Elizabeth Gowing

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

Alex E. Roher, Jonathan D. Lowenson, Steven Clarke et al. · Proceedings of the National Academy of Sciences · 1993 · 738 citations · Full text

Pathology, Vascular Amyloid, Alzheimer's Disease +20

Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease

Elizabeth Gowing, Alex E. Roher, Amina S. Woods et al. · Journal of Biological Chemistry · 1994 · 220 citations · Full text

Diffuse Amyloid Deposits, Alzheimer's Disease, Biochemistry +15

Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis

Marc‐André Lécuyer, Olivia Saint‐Laurent, Lyne Bourbonnière et al. · Proceedings of the National Academy of Sciences · 2017 · 101 citations · Full text

Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology

Claudio Derada Troletti, Ruud D. Fontijn, Elizabeth Gowing et al. · Cell Death and Disease · 2019 · 91 citations · Full text

Interleukin-26, preferentially produced by T _H 17 lymphocytes, regulates CNS barrier function

Bieke Broux, Stéphanie Zandee, Elizabeth Gowing et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 51 citations · Full text